top of page

The next generation of disruptive companies built from
ground-breaking science

A rapid and flexible path to scale radical technologies and innovations into successful ventures


Nutrecon is an expert vehicle designed to catalyse and accelerate the development of synthetic biology

Our mission is to empower exceptional teams who push the boundaries of science, with a focus on addressing urgent, unmet global needs. 

We strive to provide customized and innovative solutions that can create a positive impact on a global scale.

Are you challenging the limits of science?



Production of novel food, high-value materials and chemicals, without compromising natural resources.



Enabling the future of digital data storage by using genomics outside the medical field for sustainable, efficient and long-lasting data conservation.

Advanced protein


High-yield and low-cost production of food-grade proteins for human consumption strengthening sustainability and sufficiency.

Venture Partners

Alejandro Antalich nutrecon
Alejandro Antalich

Mr. Antalich is the former Chief Executive Officer of the Canadian Company ICC Labs Inc. (TSXV), the first publicly traded company in the world to sell cannabis to a federal government, bridging the gap between the stigma behind certain controlled substances and regulators. Through strategic foresight, determination, commitment, responsibility, teamwork and passion, he led ICC Labs to its successful sale to Aurora (TSX) in November 2018, one of the largest participants in the industry, a $300 million transaction. An entrepreneur and investor with a commercial instinct and vision towards business growth, with expertise in the medtech and foodtech sectors, as well in the pharmaceutical industry, operations, manufacturing and product development. A savvy negotiator that manages unique relationship building skills. Focused on innovation, biotechnology, biomedical sciences, medtechnology and clinical research, he also leads Biomind Labs Inc., a Canadian publicly traded life sciences company specialized in mental health and tailored drug delivery systems targeting specific therapeutic indications, and EvokAI Creative Labs Inc., a Canadian publicly traded company dedicated to the development of transformational and innovative technologies for the modern healthcare sector, offering integrated AI deep learning to brain health. He sits on the boards of several companies.

Simon Vumbaca

Mr. Vumbaca has over 20 years of experience as a strategic advisor to senior leaders and influencers and has worked in the background globally throughout the corporate, financial and governmental worlds. He is deeply passionate about having a holistic birds-eye approach to every unique situation, considering all the angles. Simon's broad spectrum of clients includes Formula 1 racing tracks, Moto GP riders, athletes, pharmaceuticals, footballers, agents, high-profile individuals and government officials. An expert in corporate strategy, public sector strategy, mergers & acquisitions, organizational strategy and functional strategy, with focus on turbo-boosting answers to the challenges companies face to ensure a successful outcome. He sits on the boards of several companies and can be available as a non-executive director. He works in English, Spanish, French, and Italian primarily.


Synbio Powerlabs will enable the development of disruptive biotechnologies with precision fermentation, from lab-scale experiments to large scale pilot runs.

bottom of page